Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Atovaquone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,595Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quotient & Medicines Announce First Dose Long-Acting Injectable
    Quotient & Medicines Announce First Dose Long-Acting Injectable

    28 Oct 2024

    // PRESS RELEASE

    https://www.quotientsciences.com/news/quotient-sciences-and-medicines-malaria-venture-announce-dosing-first-ever-long-acting

    PRESS RELEASE
    28 Oct 2024
    Share Share
    Enforcement Report - Week of October 23, 2024
    Enforcement Report - Week of October 23, 2024

    23 Oct 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2024-21885.pdf

    FDA
    23 Oct 2024
    Share Share
    Bionpharma Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension
    Bionpharma Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension

    18 Sep 2024

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/bionpharma-inc-issues-voluntary-nationwide-recall-atovaquone-oral-suspension-due-bacterial

    FDA
    18 Sep 2024
    Share Share
    Enforcement Report - Week of April 24, 2024
    Enforcement Report - Week of April 24, 2024

    24 Apr 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-24-2024-1488.pdf

    FDA
    24 Apr 2024
    Share Share
    AvKARE, LLC. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension
    AvKARE, LLC. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension

    02 Apr 2024

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/avkare-llc-issues-voluntary-nationwide-recall-atovaquone-oral-suspension-usp-750-mg5-ml-due

    FDA
    02 Apr 2024
    Share Share
    Enforcement Report - Week of May 17, 2023
    Enforcement Report - Week of May 17, 2023

    17 May 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-17-2023-88450.pdf

    FDA
    17 May 2023
    Share Share